Ryan Sullivan

86PUBLICATIONS

586CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsMolecular targetsTumour immunologyPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (86)

Sort by Publication Date:

|Jul 13, 2026

An anti-PMEL antibody-drug conjugate with a G<sub>q/1</sub><sub>1</sub> inhibitor payload in GNAQ/GNA11-mutant melanomas: a phase 1 trial.

|Jun 26, 2026

Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|Jun 25, 2026

Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|Jun 24, 2026

Multimodal blood based proteomic profiling reveals insights into mechanisms of immunotherapy resistance.

|Jun 01, 2026

Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.

|May 18, 2026

Lipid Nanoparticle-encapsulated mRNA-2752 Encoding Human OX40L, IL-23, and IL-36γ Plus Durvalumab Induces an Immunostimulatory Effect Within the Tumor Microenvironment in Patients with Advanced Solid Tumors.

Pageof 15

Frequent Collaborators

13 joint publications

Genevieve Marie Boland

11 joint publications

Meghan J Mooradian

10 joint publications

Keith T Flaherty

9 joint publications

Priscilla K Brastianos

Paolo A Ascierto

Michael Postow

Harriet M Kluger

Alexander Shoushtari

Michael White

Scott L Carter

Frequent Collaborators

13 joint publications

Genevieve Marie Boland

11 joint publications

Meghan J Mooradian

10 joint publications

Keith T Flaherty

9 joint publications

Priscilla K Brastianos